Cebalosa, Angelina B.
HRN: 24-48-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/23/2024
03/01/2024
IV
4.5g
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes